These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 9214927

  • 1. Infusion therapy with milrinone in the home care setting for patients who have advanced heart failure.
    Boger JE, DeLuca SL, Watkins DF, Vershave KK, Thomley AM.
    J Intraven Nurs; 1997; 20(3):148-54. PubMed ID: 9214927
    [Abstract] [Full Text] [Related]

  • 2. [Infusion of inotropic agents at home in patients with severe heart failure: an important role for the nurse practitioner].
    Ypenburg C, Verwey HF, van der Wall EE.
    Ned Tijdschr Geneeskd; 2007 Nov 03; 151(44):2426-8. PubMed ID: 18064859
    [Abstract] [Full Text] [Related]

  • 3. Home inotropic therapy in children.
    Berg AM, Snell L, Mahle WT.
    J Heart Lung Transplant; 2007 May 03; 26(5):453-7. PubMed ID: 17449413
    [Abstract] [Full Text] [Related]

  • 4. A prospective study of continuous intravenous milrinone therapy for status IB patients awaiting heart transplant at home.
    Brozena SC, Twomey C, Goldberg LR, Desai SS, Drachman B, Kao A, Popjes E, Zimmer R, Jessup M.
    J Heart Lung Transplant; 2004 Sep 03; 23(9):1082-6. PubMed ID: 15454175
    [Abstract] [Full Text] [Related]

  • 5. Outcomes associated with vasoactive therapy in patients with acute decompensated heart failure.
    Arnold LM, Crouch MA, Carroll NV, Oinonen MJ.
    Pharmacotherapy; 2006 Aug 03; 26(8):1078-85. PubMed ID: 16863484
    [Abstract] [Full Text] [Related]

  • 6. [Dobutamine therapy at home under the guidance of a nurse practitioner, either as a bridge to cardiac transplantation or as destination therapy in severe heart failure].
    Brügemann J, de Jonge-Weber AT, Rienstra M, van den Broek SA, Zijlstra F, van Veldhuisen DJ.
    Ned Tijdschr Geneeskd; 2007 Nov 03; 151(44):2460-5. PubMed ID: 18064867
    [Abstract] [Full Text] [Related]

  • 7. Milrinone, a new agent for the treatment of congestive heart failure.
    Hasegawa GR.
    Clin Pharm; 1986 Mar 03; 5(3):201-5. PubMed ID: 3514085
    [Abstract] [Full Text] [Related]

  • 8. Continuous Intravenous Milrinone Therapy in Pediatric Outpatients.
    Curley M, Liebers J, Maynard R.
    J Infus Nurs; 2017 Mar 03; 40(2):92-96. PubMed ID: 28248808
    [Abstract] [Full Text] [Related]

  • 9. Oral milrinone in severe chronic heart failure.
    Feldman AM, Baughman KL, Strobeck JE.
    N Engl J Med; 1992 Jun 04; 326(23):1565-6; author reply 1567. PubMed ID: 1579142
    [No Abstract] [Full Text] [Related]

  • 10. Inotropic therapy for heart failure--an unfulfilled promise.
    Curfman GD.
    N Engl J Med; 1991 Nov 21; 325(21):1509-10. PubMed ID: 1944430
    [No Abstract] [Full Text] [Related]

  • 11. Enoximone and milrinone--inotropic vasodilators for severe heart failure.
    Drug Ther Bull; 1991 May 13; 29(10):39-40. PubMed ID: 1834448
    [No Abstract] [Full Text] [Related]

  • 12. Home continuous positive inotropic infusion as a bridge to cardiac transplantation in patients with end-stage heart failure.
    Upadya S, Lee FA, Saldarriaga C, Verma S, Sedrakyan A, Nystrom K, Katz SD.
    J Heart Lung Transplant; 2004 Apr 13; 23(4):466-72. PubMed ID: 15063407
    [Abstract] [Full Text] [Related]

  • 13. New positive inotropic drugs in the treatment of congestive heart failure.
    Kennedy GT.
    Prog Cardiovasc Nurs; 1987 Apr 13; 2(3):100-4. PubMed ID: 2959954
    [No Abstract] [Full Text] [Related]

  • 14. Positive inotropic drug infusions for the patient with heart failure.
    Gorski LA.
    Home Care Provid; 2001 Jun 13; 6(3):78-80. PubMed ID: 11402263
    [No Abstract] [Full Text] [Related]

  • 15. [Rational and irrational approach to the inotropic agent therapy of heart failure].
    Colombo F, Libretti A.
    Clin Ter; 1988 Sep 30; 126(6):421-6. PubMed ID: 2974404
    [No Abstract] [Full Text] [Related]

  • 16. Positive inotropic drug infusions for patients with heart failure: current controversies and best practice.
    Gorski LA.
    Home Healthc Nurse; 2002 Apr 30; 20(4):244-53; quiz 253-4. PubMed ID: 11984193
    [Abstract] [Full Text] [Related]

  • 17. Oral milrinone in severe chronic heart failure.
    Desjardins S.
    N Engl J Med; 1992 Jun 04; 326(23):1565; author reply 1567. PubMed ID: 1579141
    [No Abstract] [Full Text] [Related]

  • 18. Outpatient continuous inotrope infusion as an adjunct to heart failure therapy in Duchenne muscular dystrophy.
    Cripe LH, Barber BJ, Spicer RL, Wong BL, Weidner N, Benson DW, Markham LW.
    Neuromuscul Disord; 2006 Nov 04; 16(11):745-8. PubMed ID: 17005398
    [Abstract] [Full Text] [Related]

  • 19. Reassessment of dobutamine, dopamine, and milrinone in the management of acute heart failure syndromes.
    Bayram M, De Luca L, Massie MB, Gheorghiade M.
    Am J Cardiol; 2005 Sep 19; 96(6A):47G-58G. PubMed ID: 16181823
    [Abstract] [Full Text] [Related]

  • 20. Milrinone: a positive inotropic vasodilator.
    Colucci WS, Jaski BE, Fifer MA, Wright RF, Braunwald E.
    Trans Assoc Am Physicians; 1984 Sep 19; 97():124-33. PubMed ID: 6535335
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.